Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification

An important mechanism that promoter methylation-mediated gene silencing for gene inactivation is identified in human tumorigenesis. Methylated genes have been found in breast cancer (BC) and beneficial biomarkers for early diagnosis. Prognostic assessment of breast cancer remain little known.